nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—CYP3A4—bone cancer	0.817	1	CbGaD
Reboxetine—ABCB1—Cisplatin—bone cancer	0.0012	0.298	CbGbCtD
Reboxetine—ABCB1—Doxorubicin—bone cancer	0.000804	0.2	CbGbCtD
Reboxetine—ABCB1—Methotrexate—bone cancer	0.000779	0.194	CbGbCtD
Reboxetine—CYP2D6—Doxorubicin—bone cancer	0.000758	0.188	CbGbCtD
Reboxetine—CYP3A4—Doxorubicin—bone cancer	0.000482	0.12	CbGbCtD
Reboxetine—Infection—Cisplatin—bone cancer	0.000469	0.00263	CcSEcCtD
Reboxetine—Nervous system disorder—Cisplatin—bone cancer	0.000463	0.0026	CcSEcCtD
Reboxetine—Blood creatinine increased—Epirubicin—bone cancer	0.000463	0.00259	CcSEcCtD
Reboxetine—Tachycardia—Cisplatin—bone cancer	0.000461	0.00258	CcSEcCtD
Reboxetine—Dehydration—Epirubicin—bone cancer	0.000459	0.00257	CcSEcCtD
Reboxetine—Skin disorder—Cisplatin—bone cancer	0.000459	0.00257	CcSEcCtD
Reboxetine—Hyponatraemia—Doxorubicin—bone cancer	0.000459	0.00257	CcSEcCtD
Reboxetine—Diplopia—Doxorubicin—bone cancer	0.000457	0.00256	CcSEcCtD
Reboxetine—Hyperhidrosis—Cisplatin—bone cancer	0.000457	0.00256	CcSEcCtD
Reboxetine—Liver function test abnormal—Epirubicin—bone cancer	0.000456	0.00255	CcSEcCtD
Reboxetine—Orthostatic hypotension—Epirubicin—bone cancer	0.000451	0.00253	CcSEcCtD
Reboxetine—Anorexia—Cisplatin—bone cancer	0.00045	0.00252	CcSEcCtD
Reboxetine—Breast disorder—Epirubicin—bone cancer	0.000446	0.0025	CcSEcCtD
Reboxetine—Hypotension—Cisplatin—bone cancer	0.000442	0.00247	CcSEcCtD
Reboxetine—Face oedema—Doxorubicin—bone cancer	0.000441	0.00247	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000435	0.00244	CcSEcCtD
Reboxetine—Muscular weakness—Epirubicin—bone cancer	0.000435	0.00244	CcSEcCtD
Reboxetine—Phenprocoumon—CYP3A4—bone cancer	0.000434	0.476	CrCbGaD
Reboxetine—Blood creatinine increased—Doxorubicin—bone cancer	0.000428	0.0024	CcSEcCtD
Reboxetine—Influenza—Epirubicin—bone cancer	0.000427	0.00239	CcSEcCtD
Reboxetine—Dysuria—Methotrexate—bone cancer	0.000426	0.00239	CcSEcCtD
Reboxetine—Dehydration—Doxorubicin—bone cancer	0.000425	0.00238	CcSEcCtD
Reboxetine—Paraesthesia—Cisplatin—bone cancer	0.000424	0.00238	CcSEcCtD
Reboxetine—Liver function test abnormal—Doxorubicin—bone cancer	0.000422	0.00236	CcSEcCtD
Reboxetine—Dyspnoea—Cisplatin—bone cancer	0.000421	0.00236	CcSEcCtD
Reboxetine—Erectile dysfunction—Methotrexate—bone cancer	0.00042	0.00235	CcSEcCtD
Reboxetine—Orthostatic hypotension—Doxorubicin—bone cancer	0.000417	0.00234	CcSEcCtD
Reboxetine—Breast disorder—Doxorubicin—bone cancer	0.000413	0.00231	CcSEcCtD
Reboxetine—Decreased appetite—Cisplatin—bone cancer	0.000411	0.0023	CcSEcCtD
Reboxetine—Bronchitis—Epirubicin—bone cancer	0.00041	0.0023	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000408	0.00228	CcSEcCtD
Reboxetine—Infestation NOS—Methotrexate—bone cancer	0.000407	0.00228	CcSEcCtD
Reboxetine—Infestation—Methotrexate—bone cancer	0.000407	0.00228	CcSEcCtD
Reboxetine—Muscular weakness—Doxorubicin—bone cancer	0.000403	0.00226	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000403	0.00226	CcSEcCtD
Reboxetine—Dysuria—Epirubicin—bone cancer	0.000399	0.00223	CcSEcCtD
Reboxetine—Conjunctivitis—Methotrexate—bone cancer	0.000395	0.00221	CcSEcCtD
Reboxetine—Influenza—Doxorubicin—bone cancer	0.000395	0.00221	CcSEcCtD
Reboxetine—Pollakiuria—Epirubicin—bone cancer	0.000394	0.00221	CcSEcCtD
Reboxetine—Sweating—Methotrexate—bone cancer	0.00039	0.00218	CcSEcCtD
Reboxetine—Feeling abnormal—Cisplatin—bone cancer	0.000389	0.00218	CcSEcCtD
Reboxetine—Weight decreased—Epirubicin—bone cancer	0.000386	0.00216	CcSEcCtD
Reboxetine—Hyperglycaemia—Epirubicin—bone cancer	0.000385	0.00216	CcSEcCtD
Reboxetine—Epistaxis—Methotrexate—bone cancer	0.000383	0.00215	CcSEcCtD
Reboxetine—Infestation NOS—Epirubicin—bone cancer	0.00038	0.00213	CcSEcCtD
Reboxetine—Infestation—Epirubicin—bone cancer	0.00038	0.00213	CcSEcCtD
Reboxetine—Bronchitis—Doxorubicin—bone cancer	0.00038	0.00213	CcSEcCtD
Reboxetine—Body temperature increased—Cisplatin—bone cancer	0.000374	0.00209	CcSEcCtD
Reboxetine—Conjunctivitis—Epirubicin—bone cancer	0.00037	0.00207	CcSEcCtD
Reboxetine—Urinary tract infection—Epirubicin—bone cancer	0.00037	0.00207	CcSEcCtD
Reboxetine—Dysuria—Doxorubicin—bone cancer	0.000369	0.00207	CcSEcCtD
Reboxetine—Sweating—Epirubicin—bone cancer	0.000365	0.00204	CcSEcCtD
Reboxetine—Pollakiuria—Doxorubicin—bone cancer	0.000365	0.00204	CcSEcCtD
Reboxetine—Pharyngitis—Methotrexate—bone cancer	0.000362	0.00203	CcSEcCtD
Reboxetine—Urinary tract disorder—Methotrexate—bone cancer	0.00036	0.00202	CcSEcCtD
Reboxetine—Epistaxis—Epirubicin—bone cancer	0.000359	0.00201	CcSEcCtD
Reboxetine—Urethral disorder—Methotrexate—bone cancer	0.000358	0.002	CcSEcCtD
Reboxetine—Weight decreased—Doxorubicin—bone cancer	0.000357	0.002	CcSEcCtD
Reboxetine—Sinusitis—Epirubicin—bone cancer	0.000357	0.002	CcSEcCtD
Reboxetine—Hyperglycaemia—Doxorubicin—bone cancer	0.000356	0.00199	CcSEcCtD
Reboxetine—Infestation NOS—Doxorubicin—bone cancer	0.000352	0.00197	CcSEcCtD
Reboxetine—Infestation—Doxorubicin—bone cancer	0.000352	0.00197	CcSEcCtD
Reboxetine—Visual impairment—Methotrexate—bone cancer	0.000352	0.00197	CcSEcCtD
Reboxetine—Hypersensitivity—Cisplatin—bone cancer	0.000348	0.00195	CcSEcCtD
Reboxetine—Bradycardia—Epirubicin—bone cancer	0.000348	0.00195	CcSEcCtD
Reboxetine—Rhinitis—Epirubicin—bone cancer	0.000342	0.00192	CcSEcCtD
Reboxetine—Conjunctivitis—Doxorubicin—bone cancer	0.000342	0.00192	CcSEcCtD
Reboxetine—Urinary tract infection—Doxorubicin—bone cancer	0.000342	0.00192	CcSEcCtD
Reboxetine—Eye disorder—Methotrexate—bone cancer	0.000341	0.00191	CcSEcCtD
Reboxetine—Tinnitus—Methotrexate—bone cancer	0.00034	0.00191	CcSEcCtD
Reboxetine—Asthenia—Cisplatin—bone cancer	0.000339	0.0019	CcSEcCtD
Reboxetine—Pharyngitis—Epirubicin—bone cancer	0.000339	0.0019	CcSEcCtD
Reboxetine—Cardiac disorder—Methotrexate—bone cancer	0.000339	0.0019	CcSEcCtD
Reboxetine—Sweating—Doxorubicin—bone cancer	0.000337	0.00189	CcSEcCtD
Reboxetine—Urinary tract disorder—Epirubicin—bone cancer	0.000337	0.00189	CcSEcCtD
Reboxetine—Connective tissue disorder—Epirubicin—bone cancer	0.000336	0.00188	CcSEcCtD
Reboxetine—Urethral disorder—Epirubicin—bone cancer	0.000335	0.00188	CcSEcCtD
Reboxetine—Epistaxis—Doxorubicin—bone cancer	0.000332	0.00186	CcSEcCtD
Reboxetine—Angiopathy—Methotrexate—bone cancer	0.000331	0.00185	CcSEcCtD
Reboxetine—Sinusitis—Doxorubicin—bone cancer	0.00033	0.00185	CcSEcCtD
Reboxetine—Immune system disorder—Methotrexate—bone cancer	0.00033	0.00185	CcSEcCtD
Reboxetine—Visual impairment—Epirubicin—bone cancer	0.000329	0.00184	CcSEcCtD
Reboxetine—Mediastinal disorder—Methotrexate—bone cancer	0.000329	0.00184	CcSEcCtD
Reboxetine—Chills—Methotrexate—bone cancer	0.000327	0.00183	CcSEcCtD
Reboxetine—Diarrhoea—Cisplatin—bone cancer	0.000323	0.00181	CcSEcCtD
Reboxetine—Bradycardia—Doxorubicin—bone cancer	0.000322	0.0018	CcSEcCtD
Reboxetine—Mental disorder—Methotrexate—bone cancer	0.00032	0.00179	CcSEcCtD
Reboxetine—Eye disorder—Epirubicin—bone cancer	0.000319	0.00179	CcSEcCtD
Reboxetine—Tinnitus—Epirubicin—bone cancer	0.000318	0.00178	CcSEcCtD
Reboxetine—Malnutrition—Methotrexate—bone cancer	0.000318	0.00178	CcSEcCtD
Reboxetine—Cardiac disorder—Epirubicin—bone cancer	0.000317	0.00178	CcSEcCtD
Reboxetine—Rhinitis—Doxorubicin—bone cancer	0.000317	0.00177	CcSEcCtD
Reboxetine—Pharyngitis—Doxorubicin—bone cancer	0.000314	0.00176	CcSEcCtD
Reboxetine—Urinary tract disorder—Doxorubicin—bone cancer	0.000312	0.00175	CcSEcCtD
Reboxetine—Dysgeusia—Methotrexate—bone cancer	0.000311	0.00174	CcSEcCtD
Reboxetine—Connective tissue disorder—Doxorubicin—bone cancer	0.000311	0.00174	CcSEcCtD
Reboxetine—Angiopathy—Epirubicin—bone cancer	0.00031	0.00174	CcSEcCtD
Reboxetine—Urethral disorder—Doxorubicin—bone cancer	0.00031	0.00174	CcSEcCtD
Reboxetine—Immune system disorder—Epirubicin—bone cancer	0.000308	0.00173	CcSEcCtD
Reboxetine—Mediastinal disorder—Epirubicin—bone cancer	0.000308	0.00172	CcSEcCtD
Reboxetine—Chills—Epirubicin—bone cancer	0.000306	0.00172	CcSEcCtD
Reboxetine—Visual impairment—Doxorubicin—bone cancer	0.000305	0.00171	CcSEcCtD
Reboxetine—Vomiting—Cisplatin—bone cancer	0.0003	0.00168	CcSEcCtD
Reboxetine—Mental disorder—Epirubicin—bone cancer	0.000299	0.00168	CcSEcCtD
Reboxetine—Rash—Cisplatin—bone cancer	0.000298	0.00167	CcSEcCtD
Reboxetine—Dermatitis—Cisplatin—bone cancer	0.000298	0.00167	CcSEcCtD
Reboxetine—Malnutrition—Epirubicin—bone cancer	0.000297	0.00167	CcSEcCtD
Reboxetine—Eye disorder—Doxorubicin—bone cancer	0.000295	0.00165	CcSEcCtD
Reboxetine—Ill-defined disorder—Methotrexate—bone cancer	0.000295	0.00165	CcSEcCtD
Reboxetine—Tinnitus—Doxorubicin—bone cancer	0.000295	0.00165	CcSEcCtD
Reboxetine—Anaemia—Methotrexate—bone cancer	0.000294	0.00164	CcSEcCtD
Reboxetine—Cardiac disorder—Doxorubicin—bone cancer	0.000293	0.00164	CcSEcCtD
Reboxetine—Tension—Epirubicin—bone cancer	0.000292	0.00163	CcSEcCtD
Reboxetine—Dysgeusia—Epirubicin—bone cancer	0.000291	0.00163	CcSEcCtD
Reboxetine—Nervousness—Epirubicin—bone cancer	0.000289	0.00162	CcSEcCtD
Reboxetine—Angiopathy—Doxorubicin—bone cancer	0.000287	0.00161	CcSEcCtD
Reboxetine—Malaise—Methotrexate—bone cancer	0.000287	0.0016	CcSEcCtD
Reboxetine—Immune system disorder—Doxorubicin—bone cancer	0.000285	0.0016	CcSEcCtD
Reboxetine—Vertigo—Methotrexate—bone cancer	0.000285	0.0016	CcSEcCtD
Reboxetine—Mediastinal disorder—Doxorubicin—bone cancer	0.000285	0.0016	CcSEcCtD
Reboxetine—Leukopenia—Methotrexate—bone cancer	0.000284	0.00159	CcSEcCtD
Reboxetine—Chills—Doxorubicin—bone cancer	0.000284	0.00159	CcSEcCtD
Reboxetine—Nausea—Cisplatin—bone cancer	0.000281	0.00157	CcSEcCtD
Reboxetine—Mental disorder—Doxorubicin—bone cancer	0.000277	0.00155	CcSEcCtD
Reboxetine—Ill-defined disorder—Epirubicin—bone cancer	0.000276	0.00155	CcSEcCtD
Reboxetine—Malnutrition—Doxorubicin—bone cancer	0.000275	0.00154	CcSEcCtD
Reboxetine—Anaemia—Epirubicin—bone cancer	0.000275	0.00154	CcSEcCtD
Reboxetine—Agitation—Epirubicin—bone cancer	0.000273	0.00153	CcSEcCtD
Reboxetine—Atomoxetine—CYP3A4—bone cancer	0.000271	0.297	CrCbGaD
Reboxetine—Chest pain—Methotrexate—bone cancer	0.00027	0.00152	CcSEcCtD
Reboxetine—Tension—Doxorubicin—bone cancer	0.00027	0.00151	CcSEcCtD
Reboxetine—Dysgeusia—Doxorubicin—bone cancer	0.000269	0.00151	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000269	0.0015	CcSEcCtD
Reboxetine—Malaise—Epirubicin—bone cancer	0.000268	0.0015	CcSEcCtD
Reboxetine—Discomfort—Methotrexate—bone cancer	0.000267	0.0015	CcSEcCtD
Reboxetine—Nervousness—Doxorubicin—bone cancer	0.000267	0.0015	CcSEcCtD
Reboxetine—Vertigo—Epirubicin—bone cancer	0.000267	0.0015	CcSEcCtD
Reboxetine—Syncope—Epirubicin—bone cancer	0.000267	0.00149	CcSEcCtD
Reboxetine—Leukopenia—Epirubicin—bone cancer	0.000266	0.00149	CcSEcCtD
Reboxetine—Palpitations—Epirubicin—bone cancer	0.000263	0.00147	CcSEcCtD
Reboxetine—Confusional state—Methotrexate—bone cancer	0.000261	0.00146	CcSEcCtD
Reboxetine—Loss of consciousness—Epirubicin—bone cancer	0.000261	0.00146	CcSEcCtD
Reboxetine—Infection—Methotrexate—bone cancer	0.000258	0.00144	CcSEcCtD
Reboxetine—Hypertension—Epirubicin—bone cancer	0.000257	0.00144	CcSEcCtD
Reboxetine—Ill-defined disorder—Doxorubicin—bone cancer	0.000255	0.00143	CcSEcCtD
Reboxetine—Nervous system disorder—Methotrexate—bone cancer	0.000254	0.00142	CcSEcCtD
Reboxetine—Anaemia—Doxorubicin—bone cancer	0.000254	0.00142	CcSEcCtD
Reboxetine—Chest pain—Epirubicin—bone cancer	0.000253	0.00142	CcSEcCtD
Reboxetine—Agitation—Doxorubicin—bone cancer	0.000253	0.00142	CcSEcCtD
Reboxetine—Anxiety—Epirubicin—bone cancer	0.000252	0.00141	CcSEcCtD
Reboxetine—Skin disorder—Methotrexate—bone cancer	0.000252	0.00141	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000251	0.00141	CcSEcCtD
Reboxetine—Hyperhidrosis—Methotrexate—bone cancer	0.000251	0.0014	CcSEcCtD
Reboxetine—Discomfort—Epirubicin—bone cancer	0.00025	0.0014	CcSEcCtD
Reboxetine—Malaise—Doxorubicin—bone cancer	0.000248	0.00139	CcSEcCtD
Reboxetine—Dry mouth—Epirubicin—bone cancer	0.000248	0.00139	CcSEcCtD
Reboxetine—Vertigo—Doxorubicin—bone cancer	0.000247	0.00138	CcSEcCtD
Reboxetine—Anorexia—Methotrexate—bone cancer	0.000247	0.00138	CcSEcCtD
Reboxetine—Syncope—Doxorubicin—bone cancer	0.000247	0.00138	CcSEcCtD
Reboxetine—Leukopenia—Doxorubicin—bone cancer	0.000246	0.00138	CcSEcCtD
Reboxetine—Confusional state—Epirubicin—bone cancer	0.000245	0.00137	CcSEcCtD
Reboxetine—Palpitations—Doxorubicin—bone cancer	0.000243	0.00136	CcSEcCtD
Reboxetine—Hypotension—Methotrexate—bone cancer	0.000242	0.00136	CcSEcCtD
Reboxetine—Loss of consciousness—Doxorubicin—bone cancer	0.000242	0.00135	CcSEcCtD
Reboxetine—Infection—Epirubicin—bone cancer	0.000241	0.00135	CcSEcCtD
Reboxetine—Shock—Epirubicin—bone cancer	0.000239	0.00134	CcSEcCtD
Reboxetine—Nervous system disorder—Epirubicin—bone cancer	0.000238	0.00133	CcSEcCtD
Reboxetine—Hypertension—Doxorubicin—bone cancer	0.000238	0.00133	CcSEcCtD
Reboxetine—Tachycardia—Epirubicin—bone cancer	0.000237	0.00133	CcSEcCtD
Reboxetine—Skin disorder—Epirubicin—bone cancer	0.000236	0.00132	CcSEcCtD
Reboxetine—Hyperhidrosis—Epirubicin—bone cancer	0.000235	0.00131	CcSEcCtD
Reboxetine—Insomnia—Methotrexate—bone cancer	0.000235	0.00131	CcSEcCtD
Reboxetine—Chest pain—Doxorubicin—bone cancer	0.000234	0.00131	CcSEcCtD
Reboxetine—Anxiety—Doxorubicin—bone cancer	0.000233	0.00131	CcSEcCtD
Reboxetine—Paraesthesia—Methotrexate—bone cancer	0.000233	0.0013	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000233	0.0013	CcSEcCtD
Reboxetine—Discomfort—Doxorubicin—bone cancer	0.000231	0.0013	CcSEcCtD
Reboxetine—Anorexia—Epirubicin—bone cancer	0.000231	0.0013	CcSEcCtD
Reboxetine—Dyspnoea—Methotrexate—bone cancer	0.000231	0.00129	CcSEcCtD
Reboxetine—Somnolence—Methotrexate—bone cancer	0.000231	0.00129	CcSEcCtD
Reboxetine—Dry mouth—Doxorubicin—bone cancer	0.000229	0.00128	CcSEcCtD
Reboxetine—Dyspepsia—Methotrexate—bone cancer	0.000228	0.00128	CcSEcCtD
Reboxetine—Hypotension—Epirubicin—bone cancer	0.000227	0.00127	CcSEcCtD
Reboxetine—Confusional state—Doxorubicin—bone cancer	0.000226	0.00127	CcSEcCtD
Reboxetine—Decreased appetite—Methotrexate—bone cancer	0.000225	0.00126	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000224	0.00125	CcSEcCtD
Reboxetine—Infection—Doxorubicin—bone cancer	0.000223	0.00125	CcSEcCtD
Reboxetine—Shock—Doxorubicin—bone cancer	0.000221	0.00124	CcSEcCtD
Reboxetine—Nervous system disorder—Doxorubicin—bone cancer	0.00022	0.00123	CcSEcCtD
Reboxetine—Insomnia—Epirubicin—bone cancer	0.000219	0.00123	CcSEcCtD
Reboxetine—Tachycardia—Doxorubicin—bone cancer	0.000219	0.00123	CcSEcCtD
Reboxetine—Skin disorder—Doxorubicin—bone cancer	0.000218	0.00122	CcSEcCtD
Reboxetine—Paraesthesia—Epirubicin—bone cancer	0.000218	0.00122	CcSEcCtD
Reboxetine—Hyperhidrosis—Doxorubicin—bone cancer	0.000217	0.00122	CcSEcCtD
Reboxetine—Dyspnoea—Epirubicin—bone cancer	0.000216	0.00121	CcSEcCtD
Reboxetine—Somnolence—Epirubicin—bone cancer	0.000216	0.00121	CcSEcCtD
Reboxetine—Anorexia—Doxorubicin—bone cancer	0.000214	0.0012	CcSEcCtD
Reboxetine—Feeling abnormal—Methotrexate—bone cancer	0.000214	0.0012	CcSEcCtD
Reboxetine—Dyspepsia—Epirubicin—bone cancer	0.000214	0.0012	CcSEcCtD
Reboxetine—Gastrointestinal pain—Methotrexate—bone cancer	0.000212	0.00119	CcSEcCtD
Reboxetine—Decreased appetite—Epirubicin—bone cancer	0.000211	0.00118	CcSEcCtD
Reboxetine—Hypotension—Doxorubicin—bone cancer	0.00021	0.00118	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000209	0.00117	CcSEcCtD
Reboxetine—Constipation—Epirubicin—bone cancer	0.000208	0.00116	CcSEcCtD
Reboxetine—Orphenadrine—CYP3A4—bone cancer	0.000207	0.227	CrCbGaD
Reboxetine—Urticaria—Methotrexate—bone cancer	0.000206	0.00115	CcSEcCtD
Reboxetine—Body temperature increased—Methotrexate—bone cancer	0.000205	0.00115	CcSEcCtD
Reboxetine—Abdominal pain—Methotrexate—bone cancer	0.000205	0.00115	CcSEcCtD
Reboxetine—Insomnia—Doxorubicin—bone cancer	0.000203	0.00114	CcSEcCtD
Reboxetine—Paraesthesia—Doxorubicin—bone cancer	0.000202	0.00113	CcSEcCtD
Reboxetine—Dyspnoea—Doxorubicin—bone cancer	0.0002	0.00112	CcSEcCtD
Reboxetine—Feeling abnormal—Epirubicin—bone cancer	0.0002	0.00112	CcSEcCtD
Reboxetine—Somnolence—Doxorubicin—bone cancer	0.0002	0.00112	CcSEcCtD
Reboxetine—Gastrointestinal pain—Epirubicin—bone cancer	0.000198	0.00111	CcSEcCtD
Reboxetine—Dyspepsia—Doxorubicin—bone cancer	0.000198	0.00111	CcSEcCtD
Reboxetine—Decreased appetite—Doxorubicin—bone cancer	0.000195	0.00109	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000194	0.00109	CcSEcCtD
Reboxetine—Urticaria—Epirubicin—bone cancer	0.000193	0.00108	CcSEcCtD
Reboxetine—Constipation—Doxorubicin—bone cancer	0.000192	0.00108	CcSEcCtD
Reboxetine—Abdominal pain—Epirubicin—bone cancer	0.000192	0.00107	CcSEcCtD
Reboxetine—Body temperature increased—Epirubicin—bone cancer	0.000192	0.00107	CcSEcCtD
Reboxetine—Hypersensitivity—Methotrexate—bone cancer	0.000191	0.00107	CcSEcCtD
Reboxetine—Asthenia—Methotrexate—bone cancer	0.000186	0.00104	CcSEcCtD
Reboxetine—Feeling abnormal—Doxorubicin—bone cancer	0.000185	0.00104	CcSEcCtD
Reboxetine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000184	0.00103	CcSEcCtD
Reboxetine—Hypersensitivity—Epirubicin—bone cancer	0.000179	0.001	CcSEcCtD
Reboxetine—Urticaria—Doxorubicin—bone cancer	0.000178	0.000999	CcSEcCtD
Reboxetine—Abdominal pain—Doxorubicin—bone cancer	0.000177	0.000994	CcSEcCtD
Reboxetine—Body temperature increased—Doxorubicin—bone cancer	0.000177	0.000994	CcSEcCtD
Reboxetine—Diarrhoea—Methotrexate—bone cancer	0.000177	0.000994	CcSEcCtD
Reboxetine—Asthenia—Epirubicin—bone cancer	0.000174	0.000975	CcSEcCtD
Reboxetine—Dizziness—Methotrexate—bone cancer	0.000171	0.00096	CcSEcCtD
Reboxetine—Diarrhoea—Epirubicin—bone cancer	0.000166	0.00093	CcSEcCtD
Reboxetine—Hypersensitivity—Doxorubicin—bone cancer	0.000165	0.000927	CcSEcCtD
Reboxetine—Vomiting—Methotrexate—bone cancer	0.000165	0.000923	CcSEcCtD
Reboxetine—Rash—Methotrexate—bone cancer	0.000163	0.000916	CcSEcCtD
Reboxetine—Dermatitis—Methotrexate—bone cancer	0.000163	0.000915	CcSEcCtD
Reboxetine—Headache—Methotrexate—bone cancer	0.000162	0.00091	CcSEcCtD
Reboxetine—Asthenia—Doxorubicin—bone cancer	0.000161	0.000902	CcSEcCtD
Reboxetine—Dizziness—Epirubicin—bone cancer	0.00016	0.000899	CcSEcCtD
Reboxetine—Vomiting—Epirubicin—bone cancer	0.000154	0.000864	CcSEcCtD
Reboxetine—Nausea—Methotrexate—bone cancer	0.000154	0.000863	CcSEcCtD
Reboxetine—Diarrhoea—Doxorubicin—bone cancer	0.000154	0.00086	CcSEcCtD
Reboxetine—Rash—Epirubicin—bone cancer	0.000153	0.000857	CcSEcCtD
Reboxetine—Dermatitis—Epirubicin—bone cancer	0.000153	0.000856	CcSEcCtD
Reboxetine—Headache—Epirubicin—bone cancer	0.000152	0.000851	CcSEcCtD
Reboxetine—Dizziness—Doxorubicin—bone cancer	0.000148	0.000832	CcSEcCtD
Reboxetine—Nausea—Epirubicin—bone cancer	0.000144	0.000807	CcSEcCtD
Reboxetine—Vomiting—Doxorubicin—bone cancer	0.000143	0.0008	CcSEcCtD
Reboxetine—Rash—Doxorubicin—bone cancer	0.000142	0.000793	CcSEcCtD
Reboxetine—Dermatitis—Doxorubicin—bone cancer	0.000141	0.000792	CcSEcCtD
Reboxetine—Headache—Doxorubicin—bone cancer	0.000141	0.000788	CcSEcCtD
Reboxetine—Nausea—Doxorubicin—bone cancer	0.000133	0.000747	CcSEcCtD
